Dear , Van here again... Just a reminder that Early Stage Trader closes in a couple hours... and won't open again (at the earliest) until 2021. These stocks are tiny. And membership levels must be kept small. Click here to review tonight's special offer before it expires... Here is the email I sent this morning with full details: Hey... Tonight is the night! As you know, Jeff Brown, America's most accurate tech investor—and one of the best early-stage investors in the world—recently sat down with me for a special Event, Penny IPOs: The "4X Window." Jeff shared with us the small class of early-stage tech biotech stocks he discovered that... - Went up 98% in a 5-year backtest he conducted—with a peak gain of 227% on average!
- Are even smaller than Amazon was in 1997, before it shot up 2,000X...
- And usually go up dramatically starting October 1st, when the "4X Window" starts up.
In fact, Jeff launched his proprietary research service — Early Stage Trader — ahead of last year's 4X Window. And JUST ONE of his recommendations shot up 432%! (So far, on closed positions, his Penny IPO recommendations are averaging 259%... in less than 4 months' time. Where else are you seeing someone averaging 259%?) These big gains all have to do with the very predictable way quality, early-stage biotech stocks move up. Because of the Federal Government, these companies HAVE to release their results! When you add in the method Jeff has determined when the exact right time is to buy into these stocks... It's no wonder he's been so successful. Well... Sadly, if you want to take advantage of these life-changing Penny IPO stocks, this is it. Tonight is the night. Because... when the clock strikes midnight, Early Stage Trader is officially closing up to new subscribers. Please don't email. Please don't call. It will already be too late. That's because — tomorrow — the "4X Window" officially begins. And there are already 3 BIG biotech conferences scheduled! Any one of Jeff's top 3 Penny IPOs right now (which you will instantly receive a full write-up on as soon as you join Early Stage Trader) could shoot up significantly... Just like Karuna Therapeutics, for example, did last year... $5,000 could've turned into nearly $43,000 in a day and a half! If you are in a position to act, now is the time. You can fill in your information to sign-up for a trial subscription to Jeff's Early Stage Trader right here. Because of Jeff's generous "$100K by May" personal model portfolio pledge... and the 100% credit guarantee... You have virtually nothing to lose. But a potential six-figure windfall to gain. Once again, after tonight, the service will shut down to new members until 2021, at the earliest. And the next explosive "4X Window" — when twice as many catalysts hit... and the gains are twice as high — only happens in October of 2021... That's a year away! What could happen THIS year... because of the increased attention biotech stocks are getting because of Covid-19... and with all the attention (and money!) billionaires like Jeff Bezos, Warren Buffett and Bill Gates are putting in Penny IPO-like stocks... Well, let's just say the gains we could see in the next 5 to 6 weeks could be historic. The only question is: Are you going to play this hand... or sit this one out? Your choice. Regards, Van Bryan
Managing Editor, Brownstone Research P.S. If—and when—Jeff chooses to open up Early Stage Trader again. There is a good chance that the retail price of $5,000 goes up. Remember, tonight you can try out the service — virtually risk-free trial basis — for half off — for only $2,500. To review the full offer and make your final decision, click here. P.P.S. If you have any final questions about this research service before signing up, please call Shanikka or her team at 1-888-512-0726. They will be picking up calls on this final day until 5 pm Eastern tonight. | 
No comments:
Post a Comment